Md Shoaib Alam

Mr. Md Shoaib Alam

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2020 in Therapeutic Delivery
Verified
Journal Article
Closed access
MAMd Shoaib Alam
Md Shoaib Alam
MAMohammed Algahtani
Mohammed Algahtani
Javed AhmadJaved Ahmad
Javed Ahmad
KKKanchan Kohli
Kanchan Kohli
SSSheikh Shafiq-Un-Nabi
Sheikh Shafiq-Un-Nabi
Mohammad Zaki AhmadMohammad Zaki Ahmad
Mohammad Zaki Ahmad
Aim: The current study aimed to explore the feasibility of the nanoemulgel for the topical delivery of aceclofenac. Materials & methods: Solubility of drugs in the formulation systems was determine...

5 June 2020 in Cosmetics
Verified
Journal Article
Open access
PDF file
MAMd Shoaib Alam
Md Shoaib Alam
MAMohammed Algahtani
Mohammed Algahtani
Mohammad Zaki AhmadMohammad Zaki Ahmad
Mohammad Zaki Ahmad
Javed AhmadJaved Ahmad
Javed Ahmad
The current study aims to utilize the concept of the hydrophilic–lipophilic balance (HLB) value of ingredients for the development of a stable emulsion-based moisturizing cream and lotion for cosmetic application. The combination of a hydrophilic and lipophilic emulsifier such as glyceryl stearate (HLB value 3.8) and PEG-100 stearate (HLB value 18.8) were found to be effective to emulsify the chosen oil phase system at a specific concentration to achieve the required HLB for the development of the stable emulsion-based system. The developed formulation was characterized for pH, viscosity, spreadability, rheology, and droplet morphology. The influence of carbopol® ETD 2020 and the concentration of the oil phase on the rheology of the product was investigated and found to be significant to achieve the required thickening to convert the lotion into a cream. The formulation system developed through utilizing the concept of HLB was compared to a product developed through the conventional approach. It was observed that the utilization of the HLB method for the development of an emulsion-based product is a promising strategy compared to the conventional method. The physical stability and thermodynamic stability tests were carried out under different storage conditions. It was observed that the developed formulation was able to retain its integrity without showing any signs of instability during storage.

9 August 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
NANabil A. Alhakamy
Nabil A. Alhakamy
SKSabna Kotta
Sabna Kotta
JAJaved Ali
Javed Ali
MAMd Shoaib Alam
Md Shoaib Alam
KHKhaled Hosny
Khaled Hosny
Shadab MDShadab MD
Shadab MD
Pain is a common distress in chronic inflammatory diseases, and etoricoxib (ETB) is frequently used in its management. It possesses fewer adverse effects when compared with other non-steroidal anti-inflammatory drugs (NSAIDs). In the present study, ETB-loaded nanoemulsion (ETB-NE) was formulated and optimized. Eucalyptus oil, Tween 20, and PEG 200 were chosen as the oil, surfactant, and co-surfactant, respectively. The formulation was optimized using the Box–Behnken design. The optimized ETB-NE contained oil, Smix, and water in concentrations of 11.5, 38, and 50% respectively. It had droplet size, polydispersity index, and zeta potential values of 179.6 ± 4.21 nm, 0.373 ± 0.02, and −10.9 ± 1.01 mV, respectively. The optimized ETB-NE sample passed the thermodynamic stability and dispersibility tests. Transmission electron microscopy confirmed the spherical morphology of the NE droplets. The ETB-NE showed a biphasic drug release pattern and released 85.3 ± 1.8% of ETB at 12 h. The ETB-NE was formulated into nanoemulsion gel (NEG) by using 1% carbopol 934. ETB-NEG was characterized for pH, viscosity, drug content, and percentage entrapment efficiency. During in vitro permeation studies, the apparent permeability coefficient value was 0.072 cm−2 h−1 for ETB-NEG, while it was only 0.047 cm−2 h−1 for the ETB gel. The skin histopathology study results confirmed that the ETB-NEG formulation was non-irritant and safe for topical use. The maximum possible analgesia observed for ETB-NEG was significantly high (p < 0.05) with a value of 47.09% after 60 min. Similarly, a formalin-induced acute inflammatory pain study in rats also demonstrated higher analgesia for the ETB-NEG, with % inhibition values of 37.37 ± 5.9 and 51.95 ± 4.4 in the acute and late phases, respectively. Further, ETB-NEG showed 78.4 ± 3.5% inhibition at 8 h in the in vivo anti-inflammatory testing by rat paw edema method. The ETB-NEG was found to enhance the in vivo analgesic and anti-inflammatory effects of ETB. The study results could stimulate further studies in this area for establishing a clinically successful NEG formulation of ETB.

6 January 2023 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
MAMd Shoaib Alam
Md Shoaib Alam
AAArif Ansari
Arif Ansari
IAIftikhar Ahsan
Iftikhar Ahsan
SSSheikh Shafiq‐Un‐Nabi
Sheikh Shafiq‐Un‐Nabi
SHShadab
Shadab
JAJaved Ahmad
Javed Ahmad
Background: Scar formation is undesirable both cosmetically and functionally. It shows that silicone gel is effective in preventing and improving scars formed due to a wound formation after injury.Objectives: This study investigates whether a silicone gel composition based on a novel concept of infusing a biologically active material such as hyaluronic acid and/or salts with various polysiloxane derivatives in a specific proportion to achieve desired viscosity range and their action has a synergistic beneficial effect on skin scar after injury.Methods: We have developed a topical gel utilizing a combination of emulsifiers, sodium hyaluronate, polysiloxane, and its derivatives. The method of preparation comprises mixing of aqueous phase dispersion and polysiloxanes blend under stirring at room temperature.Results: It results in the formation of a homogenous smooth gel formulation. The developed topical gel formulation was characterized for physicochemical properties, rheology, stability, and anti‐scar activity in Wistar rats. It was found that the developed formulation system consists of desirable attributes for skin applications. In vivo investigation of developed polysiloxane gel formulation for anti‐scar activity shown promising outcomes compared to marketed product (Kelo‐cote scar gel). Furthermore, a histopathology study of healed skin tissues observed the formation of microscopic skin structures compared to the Kelo‐cote scar gel.Conclusions: It indicates that the combination of polysiloxanes and sodium hyaluronate resulting an improvement in anti‐scar activity compared to the marketed product containing polysiloxanes alone.

1 December 2021 in Drug Delivery Letters
Verified
Journal Article
Closed access
PDF file
RSRaja Sekhar
Raja Sekhar
MAMd Shoaib Alam
Md Shoaib Alam
IAIftikhar Ahsan
Iftikhar Ahsan
SKSenthilraja Kaliyamoorthy
Senthilraja Kaliyamoorthy
TMThusleem Mohamed
Thusleem Mohamed
SSSheikh Shafiq-Un-Nabi
Sheikh Shafiq-Un-Nabi
Introduction: Conventional enteric coating is very challenging in soft gel capsules because of their shell nature (smooth surfaces and elasticity). Soft gelatin capsules are highly sensitive to temperature, humidity and they can lose their tensile strength during the conventional coating process. Materials and Methods: Enteric soft gel capsules were prepared by the addition of enteric polymer in the gelatin shell composition by inducing the cross-linking of gelatin through chemical treatment. Results: This dual approach makes the soft gelatin capsules resist the drug release in the stomach and reliably release their contents in the intestine within a predetermined time without affecting the physical properties of soft gel capsules. Conclusions: Enteric effects of soft gel capsules are brought by a specialized synergetic technique, which is unique for the molecules, requiring intestinal drug release.